The SMi Group is proud to announce its 3rd annual conference on Managing Partnerships with CROs, due to take place on the 3rd and 4th October 2011, in Central London, UK.
The pharmaceutical and biopharmaceutical industry is facing enormous challenges. With continuing R&D cuts, both in the workforce and financially, and compound attrition at all stages, productivity is low and efficiency is of paramount importance. Eliminating drugs from the development pipeline that donít show promise early on has become essential to drug development activities.
With long-term alliances, innovative partnerships and strategic M&A's abound. It seems taking a new approach to R&D methodologies and outsourcing activities is proving to be the solution of choice for most companies to bring new therapeutics to market.